PHEG Sub-Group on Cancer (7 May 2026)
PHEG Sub-Group on Cancer (7 May 2026) European Commission Cancer Sub-Group Meeting Agenda The Event The European Commission published the agenda for the Public Health Expert Group sub-group on cancer meeting scheduled for 7 May 2026. The update provides access to the official agenda document and reflects ongoing work on cancer within EU public health […]
Incidental Findings in Lung Cancer Screening: Managing Interstitial Lung Abnormalities (ILA)
Incidental Findings in Lung Cancer Screening Managing Interstitial Lung Abnormalities (ILA) Significant Incidental Findings As the National Lung Cancer Screening Programme in the Czech Republic continues to evolve, the focus is expanding beyond tumor detection to the management of significant incidental findings. Specifically, the Czech screening framework is currently developing recommended clinical guidelines for Interstitial […]
Turn Your Back on Cancer
Turn Your Back on Cancer November 2025 – March 2026 About the “Turn Your Back on Cancer” Campaign The campaign ran from November 2025 to March 2026 and aimed at raising awareness of the possibilities of population-based cancer screening programmes. Communication Strategy A comprehensive communication strategy was implemented to integrate the topic of cancer screening […]
Launch of the WHO Classification of Tumours Evidence Explorer Tool
Launch of the WHO Classification of Tumours Evidence Explorer Tool A New Digital Resource to Support Evidence-Based Tumour Classification The Event IARC announces the launch of the WHO Classification of Tumours Evidence Explorer. The event will take place on 25 June 2026. The Tool The tool aims to improve transparency and rigour in tumour […]
IARC Monographs Evaluation of the Carcinogenicity of Tris (Chloropropyl) Phosphate, Butyraldehyde and Cumyl Hydroperoxide
IARC Monographs Evaluation of the Carcinogenicity of Tris (Chloropropyl) Phosphate, Butyraldehyde and Cumyl Hydroperoxide IARC Issues New Hazard Classifications for Three High-Volume Industrial Chemicals Evaluation IARC announces the evaluation of tris (chloropropyl) phosphate, butyraldehyde and cumyl hydroperoxide. Tris (chloropropyl) phosphate is classified as probably carcinogenic to humans, while the other two substances are classified as […]
Digital Health in the Czech Republic: A Mobile Approach to Preventive Care
Digital Health in the Czech Republic: A Mobile Approach to Preventive Care Digital Tools A Dedicated Mobile Application The Czech Republic is advancing its digital healthcare landscape with a dedicated mobile application designed to put preventive care directly into the hands of its citizens. New Version The application has been transformed from the previous version, […]
Incidental Findings in LDCT Lung Cancer Screening
Expert Series · Lung Screening Incidental Findings in LDCT Lung Cancer Screening Evidence-based strategies, real-world insights, and multidisciplinary dialogue — a dedicated webinar for radiologists, pulmonologists, and screening professionals. Register now (free) Explore program 19 May 2026 18:00–19:00 CEST Online · interactive Session overview Expert lectures + open dialogue Two 20-minute state-of-the-art presentations followed […]
Advertisement for External Researcher Recruitment for a Joint Action EUCanScreen
Advertisement for External Researcher Recruitment for the Joint Action EUCanScreen External Researcher for WP5 in EUCanScreen Project Project Overview We are seeking a qualified and experienced external researcher for the Joint Action project focused on Cancer Screening (WP5). The project, which began 22 months ago, aims to assure sustainable implementation of high-quality screening for breast, […]
Updated European Recommendations on Cervical Screening at EUROGIN 2026
Updated European Recommendations on Cervical Screening at EUROGIN 2026 New European Screening Recommendations Reflect the Impact of HPV Vaccination on Population Risk EUROGIN 2026 IARC announces updated European recommendations on cervical cancer screening at EUROGIN 2026. The recommendations introduce tailored strategies for vaccinated populations. Vaccination For cohorts with high vaccination coverage, screening intervals can be […]
HSE Expands Bowel Screening
HSE Expands Bowel Screening 116,000 More People Eligible as HSE Expands Bowel Screening to Ages 57 and 71 BowelScreen Age Range This Bowel Cancer Awareness Month, HSE BowelScreen, Ireland’s free bowel screening programme has announced the fourth expansion of its eligible age range since 2023. From 1 April 2026, the HSE is offering screening to […]